世界のラットモデル市場2022-2030:種類別(アウトブレッド、ノックアウト)、技術別(胚性幹細胞、マイクロインジェクション)、サービス別、用途別、最終用途別、地域別

【英語タイトル】Rat Model Market Size, Share & Trends Analysis Report By Type (Outbred, Knockout), By Technology (Embryonic Stem Cell, Microinjection), By Service, By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GRV22NV075)・商品コード:GRV22NV075
・発行会社(調査会社):Grand View Research
・発行日:2022年10月20日
・ページ数:200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Grand View Research社は、世界のラットモデル市場規模が、2022年から2030年の間に年平均7.81%成長し、2030年までに24.1億ドルに達すると予測しています。当調査レポートでは、ラットモデルの世界市場について総合的に調査・分析を行い、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、種類別(アウトブレッド、ノックアウト、インブレッド、ハイブリッド、その他)分析、技術別(核転移酵素、マイクロインジェクション、胚性幹細胞、その他)分析、サービス別(凍結保存、育種、再導出、遺伝子検査、その他)分析、用途別(腫瘍、神経、免疫、毒性学、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの構成でまとめています。なお、当書に掲載されている企業情報には、CHARLES RIVER LABORATORIES, INC.、ENVIGO、LABORATORY CORPORATION OF AMERICA (LABCORP)、TACONIC BIOSCIENCES, INC.、GENOWAY、TRANSVIRAGEN, INC.、JANVIER LABS、CYAGEN BIOSCIENCES、BIOMERE (BIOMEDICAL RESEARCH MODELS, INC.)などが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界のラットモデル市場規規模:種類別
- アウトブレッドラットモデルの市場規模
- ノックアウトラットモデルの市場規模
- インブレッドラットモデルの市場規模
- ハイブリッドラットモデルの市場規模
- その他ラットモデルの市場規模
・世界のラットモデル市場規規模:技術別
- 核転移酵素技術の市場規模
- マイクロインジェクション技術の市場規模
- 胚性幹細胞技術の市場規模
- その他技術の市場規模
・世界のラットモデル市場規規模:サービス別
- 凍結保存サービスの市場規模
- 育種サービスの市場規模
- 再導出サービスの市場規模
- 遺伝子検査サービスの市場規模
- その他サービスの市場規模
・世界のラットモデル市場規規模:用途別
- 腫瘍における市場規模
- 神経における市場規模
- 免疫における市場規模
- 毒性学における市場規模
- その他用途における市場規模
・世界のラットモデル市場規模:地域別
- 北米のラットモデル市場規模
- ヨーロッパのラットモデル市場規模
- アジア太平洋のラットモデル市場規模
- 中南米のラットモデル市場規模
- 中東・アフリカのラットモデル市場規模
・競争状況

Rat Model Market Growth & Trends

The global rat model market size is expected to reach USD 2.41 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.81% from 2022 to 2030. Genetically modified organisms are extensively used in research for identifying potential therapeutic targets and further validation of the same. The extensive healthcare-based research has driven the market for understanding diseases and genetic illnesses of humans.

During the COVID-19 outbreak, researchers were focused on understanding the pathogenesis and transmission of the SARS-CoV2 virus by using the readily available animal model in addition to in-vitro and ex-vivo culture systems. These models also helped in the evaluation of vaccines and antivirals for the treatment. Companies creating transgenic animals used this as a perfect opportunity to provide the scientific community with genetically modified rats for evaluation of SARS-Cov2 entry. For example, in 2020,Envigo created the hACE2 knockinrat model through CRISPR-based technology. ACE2 serving as a primary receptor facilitates the entry of the SARS-CoV2 virus and is being investigated as a potential preventative target.

Animal models continue to be significant tools for preclinical testing of potential therapeutics and understanding disease mechanisms. Increased spending on research and growing number of clinical trials are the key factors contributing to the market growth. The rising incidence of genetic diseases globally and the surge in the use of animal species to advance various groundbreaking therapies are expected to further propel the market growth. Post completion of The Human Genome Project in 2003, there have been evident advancements in synthetic and molecular biology for understanding the genetic basis of diseases. These advanced technologies and products have also made it easier to create genetically engineered models (GEM) of rats, wherein different types such as knockout, outbred, inbred, and conditioned are now available in the market.

The market is expected to observe direct competition from the mouse/mice model. The mice models have been long preferred due to their small sizes and they offer economic as well as more established choices for discovery and early stage research. However, the vast use of gene editing tools in rats and the similarity of rat and human genomes make the rat model suitable for genetic manipulation and handling of experiments, thus fueling the market expansion.

Rat Model Market Report Highlights

• By type, outbred rat held the largest share in 2021. This is due to the physiological similarity of gene changes in outbred rats as in humans, which attributes to a disease phenotype

• By technology, other technologies (CRISPR/Cas, ZFN, and more)accounted for the largest share in 2021. The advent of genome editing tools has led to custom rat model creation according to the research application, thus contributing to the market demand

• By service, the breeding segment dominated the market in 2021. This is due to the high demand for multiple rat models during experiments to assess genetic variations among a population pool

• By application, in 2021, toxicology held the largest share. Owing to the demand for medications and therapeutics, toxicology studies in rats help analyze various factors such as dosing and route of administration during preclinical stages

• By end-use, the contract research organizations held the largest share in 2021.The robust R&D settings and the multiple drug discovery programs and clinical trials are fueling the segment growth. These activities employ a wide number of rat models to mimic the human response during any treatment

• North America held the largest revenue share in 2021. Growing prevalence of diseases in this region, coupled with the focus of healthcare agencies on this, has resulted in multiple funding to academic institutes for facilitating research in rats

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.8 Global Market: Cagr Calculation
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Snapshot, 2021
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Continuous Increase In Invesments And Grants Supports Research Activities
3.2.1.2 Increase In Number Of Cro For Preclinical And Clinical Testing
3.2.1.3 Application Of Genome Editing Tools For Generation Of Rodent Models
3.2.2 Market Restraint Analysis
3.2.2.1 Ethical Issues And Government Regulations Pertaining To The Use Of Animals For Research
3.3 Penetration And Growth Prospect Mapping, 2021
3.4 Covid-19 Impact Analysis
3.5 Rat Model Market Analysis Tools
3.5.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.5.2 Porter’s Five Forces Analysis
Chapter 4 Type Business Analysis
4.1 Rat Model Market: Type Movement Analysis
4.2 Knockout
4.2.1 Global Rat Model Market For Knockout Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Outbred
4.3.1 Global Rat Model Market For Outbred Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Inbred
4.4.1 Global Rat Model Market For Inbredmarket Estimates And Forecast, 2018 – 2030 (USD Million)
4.5 Hybrid
4.5.1 Global Rat Model Market For Hybrid Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.6 Immunodeficient
4.6.1 Global Rat Model Market For Immunodeficient Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.7 Conditioned
4.7.1 Global Rat Model Market For Conditioned Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Technology business Analysis
5.1 Rat Model Market: Technology Movement Analysis
5.2 Nuclear Transferase
5.2.1 Global Rat Model Market For Nuclear Transferase Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Microinjection
5.3.1 Global Rat Model Market For Microinjection market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Embryonic Stem Cell
5.4.1 Global Rat Model Market For Embryonic Stem Cell market Estimates And Forecast, 2018 – 2030 (USD Million)
5.6 Others
5.6.1 Global Rat Model Market For Othersmarket Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Service Business Analysis
6.1 Rat Model Market: Service Movement Analysis
6.2 Cryopreservation
6.2.1 Global Rat Model Market For Cryopreservation market Estimates And Forecast, 2018-2030
6.3 Breeding
6.3.1 Global Rat Model Market for Breeding market Estimates And Forecast, 2018-2030
6.4 Rederivation
6.4.1 Global Rat Model Market for Rederivation Market Estimates And Forecast, 2018-2030
6.5 Genetic Testing
6.5.1 Global Rat Model Market for Genetic Testing Market Estimates And Forecast, 2018-2030
6.6 Quarantine Depending
6.6.1 Global Rat Model Market for Quarantine Depending Market Estimates And Forecast, 2018-2030
6.7 Others
6.7.1 Global Rat Model Market for Others Market Estimates And Forecast, 2018-2030
Chapter 7 Application Business Analysis
7.1 Rat Model Market: Application Movement Analysis
7.2 Oncology
7.2.1 Global Rat Model Market For Oncology Market Estimates And Forecast, 2018-2030
7.3 Neurology
7.3.1 Global Rat Model Market For Neurology Market Estimates And Forecast, 2018-2030
7.4 Immunology
7.4.1 Global Rat Model Market For Immunology Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.5 Toxicology
7.5.1 Global Rat Model Market For Toxicology Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.6 Other
7.6.1 Global Rat Model Market For Other Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 End-Use Business Analysis
8.1 Rat Model Market: End-Use Movement Analysis
8.2 Cros
8.2.1 Global Rat Model Market For Cros Estimates And Forecast, 2018 – 2030 (USD Million)
8.3 Academic And Research Institutes
8.3.1 Global Rat Model Market For Academic And Research Institutes Estimates And Forecast, 2018 – 2030 (USD Million)
8.4 pharmaceutical & Biotechnology Companies
8.4.1 Global Rat Model Market For pharmaceutical & Biotechnology Companies Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 9 Regional Business Analysis
9.1 Rat Model Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.3 Europe
9.3.1 Europe Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.3.2 Germany
9.3.2.1 Germany Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.3.3 France
9.3.3.1 France Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.3.4 U.K.
9.3.4.1 U.K. Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.3.5 Italy
9.3.5.1 Italy Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.3.6 Spain
9.3.6.1 Spain Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.4 Asia-Pacific
9.4.1 Asia-Pacific Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.4.3 China
9.4.3.1 China Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.4.4 India
9.4.4.1 India Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.4.5 Australia
9.4.5.1 Australia Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.5 Latin America
9.5.1 Latin America Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.6 Middle East And Africa
9.6.1 Middle-East And Africa Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.6.2 South africa
9.6.2.1 South africa Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
9.6.3 Uae
9.6.3.1 Uae Rat Model Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 10 Competitive Lanscape
10.1 Strategy Framework
10.2 Company Profiles
10.2.1 CHARLES RIVER LABORATORIES, INC.
10.2.1.1 Company overview
10.2.1.2 Financial Performance
10.2.1.3 Product benchmarking
10.2.1.4 Strategic initiatives
10.2.2 ENVIGO
10.2.2.1 Company overview
10.2.2.2 Financial Performance
10.2.2.3 Product benchmarking
10.2.2.4 Strategic initiatives
10.2.3 LABORATORY CORPORATION OF AMERICA (LABCORP)
10.2.3.1 Company overview
10.2.3.2 Financial Performance
10.2.3.3 Product benchmarking
10.2.3.4 Strategic initiatives
10.2.4 TACONIC BIOSCIENCES, INC.
10.2.4.2 Company overview
10.2.4.3 Financial Performance
10.2.4.4 Product benchmarking
10.2.4.5 Strategic initiatives
10.2.5 GENOWAY
10.2.5.1 Company overview
10.2.5.2 Financial Performance
10.2.5.3 Product benchmarking
10.2.5.4 Strategic initiatives
10.2.6 TRANSVIRAGEN, INC.
10.2.6.1 Company overview
10.2.6.2 Financial Performance
10.2.6.3 Product benchmarking
10.2.6.4 Strategic initiatives
10.2.7 JANVIER LABS
10.2.7.1 Company overview
10.2.7.2 Financial Performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 CYAGEN BIOSCIENCES
10.2.8.1 Company overview
10.2.8.2 Financial Performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 BIOMERE (BIOMEDICAL RESEARCH MODELS, INC.)
10.2.9.1 Company overview
10.2.9.2 Financial Performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives



★調査レポート[世界のラットモデル市場2022-2030:種類別(アウトブレッド、ノックアウト)、技術別(胚性幹細胞、マイクロインジェクション)、サービス別、用途別、最終用途別、地域別] (コード:GRV22NV075)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のラットモデル市場2022-2030:種類別(アウトブレッド、ノックアウト)、技術別(胚性幹細胞、マイクロインジェクション)、サービス別、用途別、最終用途別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆